Market Overview

Global Stem Cells Market 2017-2018 & 2023 - Market is Projected to Grow at a CAGR of 9.74%


Dublin, Sept. 14, 2018 (GLOBE NEWSWIRE) -- The "Global Stem Cells Market - by Product Type, Source, Application, End User, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to's offering.

The Global Stem Cells Market was worth 5.17 Billion USD in 2017 and it is estimated to grow to 9.03 Billion USD by 2023 with a CAGR of 9.74% between 2017 and 2023.

The Stem cells are the cells found in the umbilical cord blood. These cells are being used in treating a wide range of conditions like sickle cell disease, leukaemia, and multiple myeloma. Birth of the child is the only chance to collect and store these valuable stem cells, which can be used to treat over 80 diseases.

North America is expected to dominate the Global Stem Cells Market in the forecast period because of the substantial investments in the field followed by Europe. Asia-Pacific region is expected to have the highest growth rate with a CAGR of 11.6%.

Drivers Vs. Constraints

The rising prevalence of chronic diseases requiring immediate medical intervention, technological advancement in the stem cells isolation and harvesting procedures, and supportive regulatory environment for stem cells products are the reasons for the growth of the Global Stem Cells Market.

Industry Structure and Updates

In October 2017, two key vendors Athersys and Nikon CELL Innovation collaborated on MultiStem Commercial Manufacturing in Japan.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Market Overview

4. Market Dynamics

5. Global Stem Cells Market Segmentation, Forecasts and Trends - by Product Type
5.1. Adult Stem Cells
5.2. Human Embryonic Stem Cells
5.3. Induced Pluripotent Stem Cells
5.4. Others

6. Global Stem Cells Market Segmentation, Forecasts and Trends - by Source
6.1. Autologous
6.2. Allogeneic

7. Global Stem Cells Market Segmentation, Forecasts and Trends - by Application
7.1. Regenerative Medicine
7.2. Drug Discovery & Development

8. Global Stem Cells Market Segmentation, Forecasts and Trends - by End User
8.1. Therapeutic Companies
8.2. Cell & Tissue Banks
8.3. Tools & Reagent Companies
8.4. Service Companies

9. Global Stem Cells Market Segmentation, Forecasts and Trends - by Region

10. Company Market Share Analysis

11. Company Profiles

  • Astellas Pharma.
  • Athersys.
  • Cytori Therapeutics, Inc.
  • Fate Therapeutics Inc.
  • Geron Corporation.
  • Osiris Therapeutics, Inc.
  • Pluristem Therapeutics Inc.
  • Thermo Fisher Scientific.
  • Vericel Corporation.
  • ViaCyte, Inc.
  • Nikon Cell Innovation
  • Holostem Advanced Therapies
  • JCR Pharmaceuticals
  • Organogenesis
  • Beike Biotechnology
  • BrainStorm Cell Therapeutics

For more information about this report visit

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

         Laura Wood, Senior Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Stem Cells 


View Comments and Join the Discussion!

Latest Ratings

DESPKeyBancInitiates Coverage On0.0
MELIKeyBancInitiates Coverage On0.0
ABTCredit SuisseInitiates Coverage On82.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.